According to WHO data, there have been 1,406 confirmed cases of the disease in DRC, with 301 suspected cases and 438 deaths.
Running a treatment trial mid-outbreak, rather than after it, is only possible because eastern DRC has now weathered enough Ebola outbreaks to have real clinical trial infrastructure in place, a grim form of accumulated institutional capacity. Whether that capacity survives the gap until the next outbreak remains the harder, less-funded question.
The launch of a treatment trial inside an active outbreak zone reflects how far Ebola response science has moved since the West African epidemic of the mid-2010s, when no approved therapeutics existed at all. With WHO recording 1,406 confirmed cases and 438 deaths in the current DRC outbreak, running trials in real time, rather than waiting for the outbreak to end, has become the default posture, a direct result of clinical infrastructure the DRC and international partners built through previous outbreaks in the same region.
That infrastructure is itself a Pan-African story worth naming: eastern DRC has now experienced enough Ebola outbreaks that it has, in effect, become one of the world's most experienced sites for outbreak-phase clinical research, a grim but real form of accumulated institutional capacity. Trial logistics that would be extraordinarily difficult to stand up from scratch elsewhere can move faster here precisely because the systems, protocols, and trained personnel already exist from prior outbreaks.
The open question is what happens to that capacity between outbreaks. Historically, much of the specialized response infrastructure built during an active crisis atrophies once case counts fall, requiring reconstruction each time a new outbreak emerges rather than sustained investment in permanent regional capability. Whether this outbreak's response leaves behind anything more durable than the last one is the harder measure of success than the trial's results alone.
READ THE SOURCE REPORT FROM BBC →Enjoying Strata-AF™?
Sign in or sign up for a personalised feed and unlock Strata-AF™ Originals.
